Calls for weight-loss drugs like Ozempic to be subsidised for people with schizophrenia

Queensland researchers are calling for weight-loss medicines to be listed on the Pharmaceutical Benefits Scheme (PBS) for people with schizophrenia, after a trial found they didn’t affect psychotic symptoms.

The team at University of Queensland said weight gain was a major side effect of common…